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Abstract 
Background: Leptospirosis is a common zoonotic infection in the world. In patients with leptospirosis, in case of 
presence of Systemic Inflammatory Response Syndrome (SIRS), clinical and laboratory findings can be mistaken for 
sepsis due to other causes of infection. The purpose of this study is to assess the clinical and laboratory parameters of 
patients with leptospirosis in terms of the presence of SIRS and to examine the association of these with mortality.
Methods: One hundred fifty-seven patients were included in the study. The patients were classified according to the 
presence or absence of SIRS and divided into SIRS (+) and SIRS (−). Patient files were retrospectively evaluated. Clini-
cal features and laboratory data were compared, and risk factors associated with mortality were determined.
Results: SIRS (+) was found in 70 % (n = 110) of patients who had signs on admission. Comparison of the clinical 
symptoms and findings of organ systems in the SIRS (+) and SIRS (−) showed that abdominal pain and vomiting 
were significantly more common in the SIRS (+) than in the SIRS (−) (p = 0.025 and p = 0.046, respectively). BUN and 
serum creatinine levels were significantly higher in the SIRS (+) than in the SIRS (−) (p = 0.002 and p < 0.001, respec-
tively). In follow-up posterior-anterior chest radiography, pathological findings improved in 58.8 % (n = 40) of patients 
in the SIRS (+) and 27.3 % (n = 9) of patients in the SIRS (−) (p = 0.003). The mortality rate of the SIRS (+) and SIRS (−) 
was not significantly different (p = 0.868).
Conclusion: In patients with positive SIRS findings, while examining the etiology of sepsis, leptospirosis should come 
to mind especially in endemic areas for differential diagnosis. Early initiation of antibiotic and supportive therapy can 
be lifesaving in these patients.
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Background
Leptospirosis is a systemic bacterial infection caused by 
the Leptospira genus. The most frequent modes of trans-
mission of the infection to humans are consumption of 
food and water contaminated with saliva, urine, and feces 
of infected animals and penetration of mucous mem-
branes or broken skin [1]. The most consistent pathologi-
cal finding in leptospirosis is vasculitis [2]. Leptospira can 
escape the immune response of the host and survive in 
various tissues, giving rise to systemic disease in some 
cases. Leptospira was shown to cause septicemia and 
vessel injury by an unexplained mechanism [3]. Histo-
pathological changes, including generalized vasculitis 
affecting the kidney, lung, liver, brain, and meninges, 
were observed in microscopic examinations [4]. Coagula-
tion disorders resulting in hemorrhages and multi-organ 
failure can occur in patients with leptospirosis and sepsis 
[5]. Systemic Inflammatory Response Syndrome (SIRS) is 
a systemic response to infection trauma burns or other 
conditions such as cancer with symptoms including 
fever tachycardia, tachypnea and leukocytosis. Sepsis is 
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defined as presence of (probable or documented) infec-
tion together with systemic manifestations of infection 
[6].
Thus, the purpose of our study is to assess the clinical 
and laboratory parameters of patients with leptospirosis 
in terms of the presence of SIRS and to examine the asso-
ciation of these with mortality.
Methods
Data on patients admitted to the Department of Clinical 
Microbiology and Infectious Diseases of Ondokuz Mayis 
University Hospital, Gulhane Military Medical Acad-
emy, Haydarpaşa Training Hospital, and Bakirkoy Sadi 
Konuk Training and Research Hospital between January 
1991 and January 2013 were included in the study. This 
study was approved by Ondokuz Mayis University Ethics 
Committee.
Data collection and laboratory analyses
Demographic data (age, sex, profession), epidemiological 
data (contact with rodent, place of residence), and symp-
toms and findings related to the disease (fever, vomiting, 
diarrhea, headache, stomach ache, myalgia, icterus, olig-
uria, respiratory and heart rate, cough, mental changes, 
neck stiffness, hemorrhage, redness of conjunctiva, hepa-
tomegaly, hemodialysis, radiologic lung findings) were 
recorded. The duration between the onset of symptoms 
and admission to the hospital, treatment and hospitaliza-
tion duration, and use of medications were recorded, and 
the prognoses of the patients were evaluated.
The laboratory investigation included a complete 
blood count and assessment of coagulation parameters 
(prothrombin time [PT] and activated partial thrombo-
plastin time [aPTT]). Serum biochemical measurements 
included leukocyte and platelet counts, hemoglobin, 
serum potassium, aspartate aminotransferase (AST), 
alanine aminotransferase (ALT), creatinine, blood urea 
nitrogen (BUN), creatinine phosphokinase, total and 
direct bilirubin and alkaline phosphatase (ALP), C-reac-
tive protein (CRP), and erythrocyte sedimentation rate 
(ESR) levels. Chest radiography was performed to deter-
mine the presence and type of infiltration.
The sera of the patients were tested for leptospira anti-
bodies with an enzyme-linked immunosorbent assay 
(ELISA) (Virion ELISA, Institut Virion GmbH, Würz-
burg, Germany and PanBio ELISA, Brisbane, Australia) 
[7]. Blood samples taken from the patients were cultured 
in Leptospira Ellinghausen-McCullough-Johnson-Harris 
medium (Difco) for generation of leptospira species.
Definition of leptospirosis
The diagnosis of leptospirosis was made according to cri-
teria published by the Centers for Diseases Control and 
Prevention (CDC) in 2013 [8]. Patients with supportive 
and confirmed laboratory criteria according to the CDC 
guidelines for leptospirosis were included in the study. 
Those without a supportive and/or confirmed labora-
tory diagnosis were excluded from the study [8]. Micro-
scopic agglutination test (MAT) was performed in the 
spirochete laboratory of Etlik Veterinary Central Con-
trol and Research Institute (ECVCRI), Ankara, Turkey. 
Macrotube agglutination (Danke-Seien, Japan) tests were 
performed in the Clinical Microbiology Laboratory of 
Cerrahpasa Medical Faculty of Istanbul University.
Supportive criteria
A Leptospira agglutination titer of ≥200 but <800 in the 
MAT in one or more serum specimens, or demonstra-
tion of anti-Leptospira antibodies in a clinical specimen 
by indirect immunofluorescence, or demonstration of 
Leptospira in a clinical specimen by dark-field micros-
copy, or detection of Immunoglobulin (Ig) M antibodies 
against Leptospira in an acute phase serum specimen.
Confirmed criteria
Isolation of Leptospira from a clinical specimen, or a 
four-fold or greater increase in Leptospira agglutination 
titers between acute- and convalescent-phase serum 
specimens studied at the same laboratory, or demonstra-
tion of Leptospira in tissue by direct immunofluores-
cence, or a Leptospira agglutination titer of ≥800 in the 
MAT in one or more serum specimens, or detection of 
pathogenic Leptospira DNA (e.g., by PCR) in a clinical 
specimen [8]. All the patients tested positive for at least 
one of according to the CDC’s criteria for leptospirosis.
Definitions of SIRS and sepsis
The diagnosis of SIRS was made according to the criteria 
of the Surviving Sepsis Campaign: (a) body temperature 
>38  °C or <36  °C, (b) heart rate >90  beats/min, (c) res-
piratory rate >20 breaths/min or PaCO2 < 32 mmHg, (d) 
white blood cell count >12,000 cells/mm3 or <4000 cells/
mm3, or >10 % immature white blood cells. The presence 
of SIRS accompanied by infection was diagnosed as sep-
sis [6]. Based on the presence of findings associated with 
SIRS, all the patients were divided into two main groups: 
SIRS (+) and SIRS (−).
Statistical analysis
IBM SPSS for Windows (version 21.0) was used for data 
management and statistical analysis. Descriptive values 
are expressed as mean ± SD for variables with a normal 
distribution or medians and interquartile ranges for vari-
ables with an abnormal distribution. Discrete variables 
were expressed as numbers and percentages. The Kol-
mogorov–Smirnov test was used to analyze the normal 
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distribution of the variables. Following normality testing, 
independent t tests and a Mann–Whitney U test were 
used to compare continuous data. The Chi-square test 
was used in the analysis of categorical data. Multivariate 
logistic regression analysis was used to find independ-




The study consisted of 157 patients, with 129 (82  %) 
males and 28 (17 %) females. The mean age was 42 ± 18 
(range 18–75). One hundred (63  %) patients were from 
the Black Sea region, and 57 (37 %) were from different 
cities in the Marmara region. The occupational distribu-
tion was as follows: 63 (40.1 %) were farmers, 25 (16 %) 
were workers [10 (40 %) were hod carrier, 7 (28 %) were 
sewage workers, 5 (20  %) were forest workers, 3 (12  %) 
were textile workers], 22 (14 %) were military personnel, 
and 18 (11.5  %) were housewives. Ten (6.3  %) patients 
were porters, and 19 (12.1  %) were classified as “other 
occupations”. Seventy-two (45.8 %) of the patients had a 
history of contact with rodents.
Diagnosis of leptospirosis
Analysis of the patients according to the CDC criteria 
for leptospirosis revealed definitive laboratory findings 
in 31 (19.7  %) patients and supportive laboratory find-
ings in 126 (80.3 %) patients. The spiral form of leptospira 
was detected with dark field microscopy in the blood 
of 116 (74.4 %) patients. Ig M positivity was detected in 
128 (82.1 %) patients. Thirty-one (19.7 %) patients had a 
titer >200 in the MAT test, and 52 (33.1  %) had a titer 
<200. Only 9 (11.1 %) patients with sera positive findings 
by MAT had a titer ≥800. In 37 (25.5  %) patients diag-
nosed according to MAT. Culture was formed from the 
blood samples of 34 patients. Leptospira bacteria were 
isolated in 22 (14  %) of these cultures. In all patients 
whose MAT was positive, common serological lepto-
spira subtypes were as follows: L. biflexa serovar Patoc 
(42.1  %, n  =  35), L. interrogans serovar icterohaemor-
ragia (31.3  %, n =  26), L. interrogans serovar bratislava 
(12  %, n  =  10), and L. interrogans serovar grippotyhos 
(6 %, n = 5). In the macrotube agglutination analysis, the 
rates of L. interrogans serovar icterohaemorragia and L. 
interrogans serovar autumnalis were 64.9 % (n = 24) and 
35.1 % (n = 13), respectively.
Evaluation of patients according to SIRS
SIRS (+) was found in 70  % (n =  110) of patients who 
had signs on admission. Comparison of the clinical 
symptoms and findings of organ systems in the SIRS (+) 
and SIRS (−) showed that abdominal pain and vomiting 
were significantly more common in the SIRS (+) than 
in the SIRS (−) (p = 0.025 and p = 0.046, respectively). 
Additional clinical symptoms and findings are summa-
rized in Table 1. BUN and serum creatinine levels were 
significantly higher in the SIRS (+) than in the SIRS (−) 
(p  =  0.002 and p  <  0.001, respectively). The need for 
hemodialysis was not different between the SIRS (+) 
and SIRS (−) (p = 0.128). In follow-up posterior-anterior 
chest radiography, pathological findings improved in 
58.8  % (n =  40) of patients in the SIRS (+) and 27.3  % 
(n = 9) of patients in the SIRS (−) (p = 0.003). Additional 
laboratory symptoms and findings are summarized in 
Table 2.
The mean durations of complaints, treatment, and 
hospitalization were 7 ±  5, 7 ±  9, and 13 ±  11  days, 
respectively, in the SIRS (+) and 8  ±  6, 10  ±  5, and 
12 ± 13 days, respectively, in the SIRS (−). There was 
no significant difference in the mean duration of the 
complaints, treatment, and hospitalization between 
the SIRS (+) and SIRS (−) (p > 0.05). Crystalized pen-
icillin (33.8  %; n =  53), doxycycline (16.9  %; n =  27), 
ampicillin/sulbactam (21.6  %; n  =  34), and ceftriax-
one (12.8 %; n = 20) were commonly used to treat the 
patients.
The evaluation of mortality
Nineteen out of 157 patients died (12 %). The mortality 
rate of the SIRS (+) and SIRS (−) was not significantly 
different (p = 0.868) (Table 1).
Table 1 Detailed clinical symptoms of  the SIRS (+) 
and SIRS (−)








Myalgia 71 (65.1) 29 (61.7) 0.682
Jaundice 65 (59.1) 34 (72.3) 0.115
Hemorrhage 24 (21.8) 7 (14.9) 0.386
Conjunctival petechiae 28 (25.5) 9 (19.1) 0.538
Headache 55 (50.5) 23 (48.9) 0.861
Vomiting 74 (67.9) 24 (51.1) 0.046
Cough 37 (33.9) 11 (23.4) 0.257
Abdominal pain 54 (49.1) 14 (29.8) 0.025
Diarrhea 33 (30.3) 11 (23.4) 0.441
Oliguria 44 (40.4) 14 (30.4) 0.279
Change in mental status 28 (25.5) 10 (22.2) 0.837
Radiological lung findings 40 (58.8) 9 (27.3) 0.003
Neck stiffness 8 (18.6) 4 (13.8) 0.751
Hemodialysis 18 (16.4) 3 (6.7) 0.128
Hepatomegaly 38 (34.5) 20 (42.6) 0.370
Mortality 13 (11.8) 6 (12.8) 0.868
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Discussion
Patients with leptospirosis, in case of presence of SIRS, 
clinical and laboratory findings can be mistaken for 
sepsis caused by other infection factors [9, 10]. In 110 
(70  %) of our patients, SIRS was found to be positive. 
SIRS findings can present early in both leptospirosis 
and other bacterial sepsis. Patients who are admitted 
to a healthcare facility and who are found to have SIRS 
positive findings, leptospirosis should come to mind if 
the patient has a history of contact with rodent or epi-
demiological background [4]. It is probable for some of 
these patients to have sepsis. However, in order to be 
able to diagnose SIRS positive patients with sepsis, the 
agent should be reproduced in the blood culture. The 
culture of leptospira bacteria is difficult and time con-
suming since it requires special media for culture and 
reproduces late besides the technical difficulties of con-
ducting the procedure. It was possible to culture in only 
one of the three centers that participated in the study 
and leptospira bacteria were isolated in 22 (14 %). Thir-
teen (59  %) of the patients with positive culture were 
diagnosed with sepsis since they had SIRS (+). The high 
positive blood culture rates of 65 % in the centre where 
blood culture was conducted highlights how impor-
tant it is to develop means of culture for the differential 
diagnosis of leptospirosis in countries where leptospira 
is frequent.
In the course of sepsis, presence of organ involve-
ment is called sepsis syndrome. Leptospirosis may cause 
pathological changes in a great number of organs due 
to the endothelium damage it causes [9, 11]. However, 
these changes are reversible unlike the organ damage in 
sepsis. In our study, when SIRS (+) patients were com-
pared with SIRS (−) patients, high urea and creatinine 
values at first admission, gastrointestinal system findings 
(stomach pain, throwing up) and pathological findings in 
lung radiology were found to be statistically significant 
(p < 0.05). Organ involvement is a finding of sepsis syn-
drome. Organ and system involvement, especially kidney 
involvement, has been found in SIRS (+) leptospirosis 
patients. It is difficult to find out how many of these cases 
are associated with sepsis.
Seguro et  al. showed renal damage and pulmonary 
damage in the experimental leptospirosis and sepsis ani-
mal models that they conducted [12]. Acute renal failure 
is frequent in patients with leptospirosis. Renal failure 
usually develops in leptospirosis cases following acute 
interstitial nephritis and tubular and microvascular dam-
age. Cengiz et al. examined 36 leptospirosis patients and 
reported that 65 and 51 % of cases had acute renal failure 
and were non-oliguric, respectively. In addition, serum 
BUN, creatinine, AST, ALT, bilirubin, and potassium lev-
els were higher in oliguric patients than in non-oliguric 
ones (p < 0.005). Thirteen (48 %) patients required renal 
replacement therapy, and 92 % of patients recovered fully 
after 3–5 weeks [13].
Renal damage is one of the organ dysfunctions in sepsis 
[12]. Jayakumar et al. examined the reasons of acute renal 
failure in India, and reported sepsis as 8.8 % and leptospi-
rosis as 7.5 % [14]. In the present study, BUN and serum 
creatinine levels were significantly higher in the SIRS (+) 
than in the SIRS (−). The need hemodialysis was greater 
in the SIRS (+) (p = 0.128). Lung injury can also occur 
in leptospirosis cases like sepsis. As shown in many stud-
ies, severe pulmonary injury is one of the major causes 
of death in Leptospirosis [15–17]. Gouveia et al. observed 
severe lung injury in 74 % of fatal cases of leptospirosis 
[18]. Pulmonary injury increases the need for mechanical 
ventilation and intensive care [19]. It was detected that, 
pulmonary involvement was significantly higher in the 
SIRS (+) compared to the SIRS (−) (p = 0.003).
Renal and pulmonary pathological findings in patients 
with SIRS (+) should be assessed carefully and these 
findings should be considered for sepsis in leptospiro-
sis. The clinician should be careful with suitable and fast 
antibiotics treatment as well as the need for supplemen-
tary treatment. The management of risk factors that may 
affect the clinical follow-up, treatment, and prognosis of 
Table 2 Laboratory findings of  the SIRS (+) and  SIRS (−) 
patients [median (IQR), n (%), mean ± SD]
Italic values indicate statistically significant (p < 0.05)
IR interquartile range, SD standard deviation, ALP alkaline phosphatase, 
BUN blood urea nitrogen, CPK creatinine phosphokinase, ALT alanine 
aminotransferase, AST aspartate aminotransferase, CRP C-reactive protein, PT 







Hemoglobin (g/dl) 11.55 ± 2.56 12.33 ± 2.11 0.097
Leukocyte (/mm3) 12,700 (1400–
44,100)
8900 (1800–33,100) <0.001





Total bilirubin  
(mg/dL)
6.3 (0.1–83) 3.7 (0.2–54) 0.077
Direct bilirubin  
(mg/dL)
3.3 (0.1–50) 2.2 (0.1–37) 0.065
ALP (U/L) 247 (47–1594) 22.0 (39–1700) 0.592
BUN (mg/dL) 73 (5–474) 35 (5–153) 0.002
Creatinine (mg/dL) 4.1 (0.1–47) 1.4 (0.5–9.7) <0.001
Potassium (mg/dL) 4 (2.1–66) 3.8 (2.6–5.2) 0.138
CPK (U/L) 312 (19–13,043) 534 (15–2667) 0.366
AST (U/L) 90.0 (15–2797) 79.0 (24–1063) 0.463
ALT (U/L) 85.5 (19–1656) 72 (17–1575) 0.441
CRP (mg/L) 27 (2–208) 38.0 (3–208) 0.195
PT, aPTT 42 (38.5) 8 (23.5) 0.149
ESR (mm/h) 52.86 ± 32.68 51.2 ± 34.83 0.798
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patients with leptospirosis is important. Many research-
ers have investigated risk factors for mortality. Some 
studies reported that dyspnea, oliguria, white blood cell, 
abnormal repolarization on an electrocardiogram, and 
the presence of alveolar infiltrates were mortality-related 
risk factors [15, 18, 19]. Esen et al. reported that a change 
in mental status and hyperkalemia were risk factors for 
mortality [20]. In our study, no statistically significant dif-
ference was found in mortality in terms of SIRS. Accord-
ing to these results, the presence of SIRS is not a factor 
that predicts mortality. However, since our study is ret-
rospective, not having assessed comorbid situations that 
may affect mortality is a limitation.
As conclusion; the present study confirms that the clin-
ical and laboratory findings of leptospirosis are similar to 
those of sepsis. Sepsis and leptospirosis patients should 
be followed closely in terms of multi-organ involvement. 
In areas where leptospirosis is endemic, leptospirosis 
should come to mind while examining the SIRS/sepsis 
etiology.
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